Skip to content

Clinical trials

Phase 2 Waldenstrom Macroglobulinemia trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Phase: Phase 2 Country / region: Greece Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20141
20171
20191
20211
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting5
Completed2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Christian Buske3
Acerta Pharma BV1
BeOne Medicines1
Cellectar Biosciences, Inc.1
European Myeloma Network B.V.1
Meletios A. Dimopoulos1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia8
Lymphoma4
Neoplasms3
Blood Protein Disorders1
Hematologic Diseases1
Immunoproliferative Disorders1
Leukemia, Lymphocytic, Chronic, B-Cell1
Lymphoma, B-Cell, Marginal Zone1
Lymphoma, Large B-Cell, Diffuse1
Lymphoma, Mantle-Cell1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.